Pioglitazone
Pioglitazone is a pharmaceutical drug with 293 clinical trials. Currently 17 active trials ongoing. Historical success rate of 84.2%.
Success Metrics
Based on 208 completed trials
Phase Distribution
Phase Distribution
38
Early Stage
71
Mid Stage
135
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.6%
208 of 255 finished
18.4%
47 ended early
17
trials recruiting
293
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer
Clinical Trials (293)
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer
Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention
A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
Insulin Regulation of Lipolysis and Lipolysis Proteins
Quantifying Hepatic Mitochondrial Fluxes in Humans
Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
Effects of Pioglitazone on Stress Reactivity and Alcohol Craving
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
HbA1c Variability in Type II Diabetes
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients
Low-Dose Pioglitazone in Patients With NASH (AIM 2)
A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 293